January 23, 2018 / 6:09 AM / 6 months ago

BRIEF-Bone Therapeutics Cash And Cash Equivalents Of EUR 8.4 Mln At End Of 2017

Jan 23 (Reuters) - BONE THERAPEUTICS:

* REG-BONE THERAPEUTICS SA : PROVIDES BUSINESS OUTLOOK AND ANNOUNCES ITS FINANCIAL CALENDAR FOR 2018

* COMPLETION OF RECRUITMENT IN ITS PHASE IIA SPINAL FUSION TRIAL WITH ALLOB(®), FOLLOWING POSITIVE INTERIM DATA, EXPECTED IN Q1

* FINAL RESULTS EXPECTED IN PHASE I/IIA TRIAL OF ALLOB(®) IN DELAYED UNION FRACTURES IN H1

* CASH AND CASH EQUIVALENTS OF EUR 8.4 MILLION END OF 2017

* ‍INTERIM RESULTS FOR FIRST 44 PATIENTS IN PHASE III STUDY OF PREOB(®) IN OSTEONECROSIS AFTER ONE-YEAR FOLLOW-UP, WITH POTENTIAL FOR EARLY TRIAL STOP, IN H2​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below